News

Quad/Graphics Sees Notable Changes in First Quarter Results

Quad/Graphics Sees Notable Changes in First Quarter Results

Quad/Graphics First Quarter Financial Overview

Quad/Graphics, Inc. (NYSE: QUAD), a marketing experience company, has announced its financial performance for the first quarter of the year. The company reported net sales of $629 million in the first quarter of 2025, reflecting a decrease from $655 million in the same period of 2024. This decline represents a 4% decrease in net sales, or alternatively, a 2% drop on an organic basis when factoring out the divestiture of European operations that occurred earlier in the year.

Profitability Metrics Report

In the face of decreasing sales, Quad reported net earnings of $6 million, translating to $0.11 in diluted earnings per share (EPS). This marks a significant turnaround from the previous year, which saw a net loss of $28 million or $0.60 per share. Adjusted diluted earnings per share also jumped to $0.20 from $0.10 in the same quarter last year.

Adjusted Earnings and EBITDA

Non-GAAP adjusted EBITDA stood at $46 million for the quarter, a decrease from $51 million in the prior year. Overall, these results highlight a more stable financial footing compared to prior performance.

Strategic Initiatives Driving Growth

Quad continues to focus on innovation and cost savings for its clients, actively seeking solutions to enhance consumer engagement. The firm has made strategic investments, including the recent acquisition of co-mailing assets from Enru, which is anticipated to bolster operational capabilities. Additionally, Quad has expanded its In-Store Connect retail media network to include new grocery partnerships, allowing for improved consumer interaction within retail environments.

Shareholder Returns and Financial Guidance

In an effort to strengthen shareholder value, Quad repurchased a total of 1.2 million shares this year, contributing to a total of 7.2 million shares bought back since 2022. The board of directors also declared a quarterly dividend of $0.075 per share. Furthermore, the company reaffirmed its full-year guidance for 2025, expecting organic annual net sales to decline between 2% and 6%. The adjusted EBITDA is projected to range from $180 million to $220 million.

Management Commentary

Joel Quadracci, the Chairman and CEO of Quad, stated, "Our first quarter results align with our expectations, and we remain committed to achieving our financial guidance for 2025. We are focused on growing our offerings through innovative strategies while managing economic uncertainties."

Additionally, Tony Staniak, the Chief Financial Officer, emphasized that despite the prevailing macroeconomic conditions, Quad is positioned to navigate the landscape while continuing to invest in long-term growth.

Conclusion

As Quad/Graphics moves through 2025, the company is dedicated to leveraging its integrated marketing platform to drive value for clients and shareholders. Their strategic directions indicate a robust commitment to innovation and adaptive measures to enhance market presence amidst a changing economic environment.

Frequently Asked Questions

What were Quad/Graphics' net sales in Q1 2025?

The net sales for Quad/Graphics in the first quarter of 2025 were reported at $629 million.

How did Quad/Graphics' net earnings change compared to last year?

Quad reported net earnings of $6 million in Q1 2025, which is a significant improvement from a net loss of $28 million in the same quarter of 2024.

What strategies is Quad implementing for growth?

Quad is focusing on strategic investments in innovative marketing solutions and expanding its partnerships with grocery and retail clients.

What is the quarterly dividend declared by Quad?

Quad has declared a quarterly dividend of $0.075 per share.

What is the full-year guidance provided by Quad for 2025?

Quad has maintained its guidance projecting an organic annual net sales decline between 2% and 6%, with adjusted EBITDA expected to be between $180 million and $220 million.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 9

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 4

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 6

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 6

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading

Top 5 Most Recently Viewed Articles

Crunch Fitness Expands with New State-of-the-Art Facility

Updated Category News Views 448

Exciting Launch of Crunch Fitness in New Location Crunch Fitness is set to enhance the fitness experience for all in its newest location, a state-of-the-art facility designed to invigorate the community. Positioned at 4701 Colleyville Blvd, this modern gym promises to redefine conventional workout spaces. With elegant lighting and a sleek design,Crunch Colleyville aims to...

Continue Reading
Meketa Capital Unveils New Infrastructure Fund for Advisors

Updated Category News Views 57

Exciting Launch of the Meketa Infrastructure Fund Meketa Capital has made an impactful move by launching the Meketa Infrastructure Fund, which is aimed at registered investment advisors (RIAs). This fund is now accessible through Fidelity’s Institutional Wealth Services and National Financial marketplaces, expanding options for advisors and their clients. Access to a...

Continue Reading
BrightPath Child Care Expands with New School Opening

Updated Category News Views 521

BrightPath Early Learning Opens New Facility in Sugar Grove BrightPath Early Learning and Child Care, a leading provider of early childhood education, proudly announces the opening of its new location in Sugar Grove. This marks a significant milestone as it expands its reach in the Chicago area, adding another option for families seeking high-quality child care services....

Continue Reading
Baltic Horizon Fund Announces SDR Program Termination Plans

Updated Category News Views 133

Baltic Horizon Fund's Termination of SDR Program On February 13, 2025, Baltic Horizon Fund (the Fund) announced the decision to terminate its Swedish Depositary Receipts (SDR) program and subsequently delist from Nasdaq Stockholm. This significant change comes as the Fund aims to streamline its operations and enhance efficiency in the market. Notice of Termination for SDR...

Continue Reading
Cereno Scientific Advances Clinical Trials for PAH Treatment

Updated Category News Views 184

Cereno Scientific Submits Protocol for Phase IIb Trial of CS1 Cereno Scientific, a pioneering biotech, has taken a significant step forward by submitting its Phase IIb trial protocol for CS1 to the U.S. Food and Drug Administration (FDA). This submission marks an important milestone in the company's efforts to enhance healthcare for patients living with pulmonary arterial...

Continue Reading